Moderna shares sink after leaked cancer data missed expectations

2 hours ago 3

Want Your Business Featured Here?

Get instant exposure to our readers

Chat on WhatsApp
Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations
Read Entire Article
Chatroom